Status:
COMPLETED
Pentraxin-3 in Chronic Renal Failure
Lead Sponsor:
Haseki Training and Research Hospital
Conditions:
Inflammation
Chronic Kidney Disease
Eligibility:
All Genders
16-80 years
Brief Summary
The aim of the study is to measure Pentraxin-3 levels in patients on hemodialysis, peritoneal dialysis and those in the pre-dialysis period; and to compare these groups with the control group; so as t...
Detailed Description
The investigators planned to involve four group of patients: Hemodialysis, peritoneal dialysis, pre-dialysis and the control group; with about 25 patients planned to be involved in each group. The lab...
Eligibility Criteria
Inclusion
- To give informed consent
- Hemodialysis or peritoneal dialysis for more than 3 months
- Creatinin clearance less than 30 ml/min for the pre-dialysis group
Exclusion
- Not to give informed concent
- Active infection within the last 3 months
- Known chronic inflammatory disease
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT01397773
Start Date
April 1 2010
End Date
January 1 2011
Last Update
July 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haseki Training and Research Hospital
Istanbul, Turkey (Türkiye), 34390